Related references
Note: Only part of the references are listed.Novel Antitumor Platinum(II) Conjugates Containing the Nonsteroidal Anti-inflammatory Agent Diclofenac: Synthesis and Dual Mechanisms of Antiproliferative Effects
Francesco Paolo Intini et al.
INORGANIC CHEMISTRY (2017)
The Lipoxygenases: Their Regulation and Implication in Alzheimer's Disease
Grzegorz A. Czapski et al.
NEUROCHEMICAL RESEARCH (2016)
Breast Cancer Stem Cell Potent Copper(II)-Non-Steroidal Anti-Inflammatory Drug Complexes
Janine N. Boodram et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2016)
Inhibition of 5-lipoxygenase suppresses vascular endothelial growth factor-induced angiogenesis in endothelial cells
Tae Young Kim et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2016)
The Potent Inhibitory Effect of a Naproxen-Appended Cobalt(III)-Cyclam Complex on Cancer Stem Cells
Paul B. Cressey et al.
CHEMBIOCHEM (2016)
Nanostructured materials functionalized with metal complexes: In search of alternatives for administering anticancer metallodrugs
Waseem A. Wani et al.
COORDINATION CHEMISTRY REVIEWS (2016)
Fine tuning through valence bond tautomerization of ancillary ligands in ruthenium(II) arene complexes for better anticancer activity and enzyme inhibition properties
Poulami Mandal et al.
DALTON TRANSACTIONS (2016)
Platinum(IV) anticancer prodrugs - hypotheses and facts
Dan Gibson
DALTON TRANSACTIONS (2016)
Metal-based drugs that break the rules
Claire S. Allardyce et al.
DALTON TRANSACTIONS (2016)
Platinum complexes as light promoted anticancer agents: a redefined strategy for controlled activation
Koushambi Mitra
DALTON TRANSACTIONS (2016)
Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) in Metal Complexes and Their Effect at the Cellular Level
Christina N. Banti et al.
EUROPEAN JOURNAL OF INORGANIC CHEMISTRY (2016)
Tracking antitumor metallodrugs: promising agents with the Ru(II)- and Fe(II)-cyclopentadienyl scaffolds
Tania S. Morais et al.
FUTURE MEDICINAL CHEMISTRY (2016)
Nonsteroidal Anti-inflammatory-Organometallic Anticancer Compounds
Emilia Paunescu et al.
INORGANIC CHEMISTRY (2016)
Substrate-selective Inhibition of Cyclooxygeanse-2 by Fenamic Acid Derivatives Is Dependent on Peroxide Tone
Benjamin J. Orlando et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2016)
Axially-modified paddlewheel diruthenium(II,III)-ibuprofenato metallodrugs and the influence of the structural modification on U87MG and A172 human glioma cell proliferation, apoptosis, mitosis and migration
Hanif-Ur-Rehman et al.
JOURNAL OF INORGANIC BIOCHEMISTRY (2016)
Systematical investigation of binding interaction between novel ruthenium(II) arene complex with curcumin analogs and ctDNA
Shan Huang et al.
LUMINESCENCE (2016)
Targeted Drug Delivery System for Platinum-based Anticancer Drugs
Chuanzhu Gao et al.
MINI-REVIEWS IN MEDICINAL CHEMISTRY (2016)
Nickel(II) complexes of the non-steroidal anti-inflammatory drug tolfenamic acid: Synthesis, structure, antioxidant activity and interaction with albumins and calf-thymus DNA
Xanthippi Totta et al.
POLYHEDRON (2016)
Linking the future of anticancer metal-complexes to the therapy of tumour metastases
Alberta Bergamo et al.
CHEMICAL SOCIETY REVIEWS (2015)
Novel mixed metal Ag(I)-Sb(III)-metallotherapeutics of the NSAIDs, aspirin and salicylic acid: Enhancement of their solubility and bioactivity by using the surfactant CTAB
E. I. Gkaniatsou et al.
JOURNAL OF INORGANIC BIOCHEMISTRY (2015)
Novel binuclear μ-oxo diruthenium complexes combined with ibuprofen and ketoprofen: Interaction with relevant target biomolecules and anti-allergic potential
Gabriela Campos Seuanes et al.
JOURNAL OF INORGANIC BIOCHEMISTRY (2015)
Synthesis, crystal structure and spectroscopy of bioactive Cd(II) polymeric complex of the non-steroidal anti-inflammatory drug diclofenac sodium: Antiproliferative and biological activity
Leila Tabrizi et al.
SPECTROCHIMICA ACTA PART A-MOLECULAR AND BIOMOLECULAR SPECTROSCOPY (2015)
Synthesis and Evaluation of Novel Erlotinib-NSAID Conjugates as More Comprehensive Anticancer Agents
Yanmei Zhang et al.
ACS MEDICINAL CHEMISTRY LETTERS (2015)
Synthesis, Characterization and Antiproliferative Activity of Transition Metal Complexes with 3-(4,5-Diphenyl-1,3-oxazol-2-yl)propanoic Acid (Oxaprozin)
Bojan Božić et al.
CHEMICAL & PHARMACEUTICAL BULLETIN (2015)
Conjugation of Cisplatin Analogues and Cyclooxygenase Inhibitors to Overcome Cisplatin Resistance
Wilma Neumann et al.
CHEMMEDCHEM (2015)
Manganese-mefenamic acid complexes exhibit high lipoxygenase inhibitory activity
Jie Feng et al.
DALTON TRANSACTIONS (2014)
New ruthenium(II) arene complexes of anthracenyl-appended diazacycloalkanes: effect of ligand intercalation and hydrophobicity on DNA and protein binding and cleavage and cytotoxicity
Mani Ganeshpandian et al.
DALTON TRANSACTIONS (2014)
Synthesis and Structure-Activity Relationship Studies of 4-((2-Hydroxy-3-methoxybenzyl)amino)benzenesulfonamide Derivatives as Potent and Selective Inhibitors of 12-Lipoxygenase
Diane K. Luci et al.
JOURNAL OF MEDICINAL CHEMISTRY (2014)
Anticancer Ruthenium(η6-p-cymene) Complexes of Nonsteroidal Anti-inflammatory Drug Derivatives
Farhana Aman et al.
ORGANOMETALLICS (2014)
100 years of metal coordination chemistry: from Alfred Werner to anticancer metallodrugs
Nicolas P. E. Barry et al.
PURE AND APPLIED CHEMISTRY (2014)
NKP-1339, the first ruthenium-based anticancer drug on the edge to clinical application
Robert Trondl et al.
CHEMICAL SCIENCE (2014)
DMSO-Mediated Ligand Dissociation: Renaissance for Biological Activity of N-Heterocyclic-[Ru(η6-arene)Cl2] Drug Candidates
Malay Patra et al.
CHEMISTRY-A EUROPEAN JOURNAL (2013)
Quinolones and non-steroidal anti-inflammatory drugs interacting with copper(II), nickel(II), cobalt(II) and zinc(II): structural features, biological evaluation and perspectives
George Psomas et al.
DALTON TRANSACTIONS (2013)
Synthesis, Pharmacological Characterization, and Docking Analysis of a Novel Family of Diarylisoxazoles as Highly Selective Cyclooxygenase-1 (COX-1) Inhibitors
Paola Vitale et al.
JOURNAL OF MEDICINAL CHEMISTRY (2013)
A silver complex with ibuprofen: Synthesis, solid state characterization, DFT calculations and antibacterial assays
Irlene Maria Pereira e Silva et al.
JOURNAL OF MOLECULAR STRUCTURE (2013)
Targeting the DNA-topoisomerase complex in a double-strike approach with a topoisomerase inhibiting moiety and covalent DNA binder
Andrea Kurzwernhart et al.
CHEMICAL COMMUNICATIONS (2012)
Synthesis and characterization of a diruthenium(II,III)-ketoprofen compound and study of the in vitro effects on CRC cells in comparison to the naproxen and ibuprofen derivatives
Rodrigo L. S. R. Santos et al.
POLYHEDRON (2012)
Metal-based antitumour drugs in the post-genomic era: what comes next?
Gianni Sava et al.
DALTON TRANSACTIONS (2011)
Ruthenium anticancer compounds: myths and realities of the emerging metal-based drugs
Alberta Bergamo et al.
DALTON TRANSACTIONS (2011)
Binding of Ibuprofen, Ketorolac, and Diclofenac to COX-1 and COX-2 Studied by Saturation Transfer Difference NMR
Aldino Viegas et al.
JOURNAL OF MEDICINAL CHEMISTRY (2011)
(R)-Profens are substrate-selective inhibitors of endocannabinoid oxygenation by COX-2
Kelsey C. Duggan et al.
NATURE CHEMICAL BIOLOGY (2011)
[Cyclopentadienyl]metalcarbonyl complexes of acetylsalicylic acid as neo-anticancer agents
Gerhard Rubner et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2010)
Synthesis and antiproliferative properties of ibuprofen-oligo(3-hydroxybutyrate) conjugates
Barbara Zawidlak-Wegrzynska et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2010)
Is the Reactivity of M(II)-Arene Complexes of 3-Hydroxy-2(1H)-pyridones to Biomolecules the Anticancer Activity Determining Parameter?
Muhammad Hanif et al.
INORGANIC CHEMISTRY (2010)
Rational Design of an Organometallic Glutathione Transferase Inhibitor
Wee Han Ang et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2009)
The interactions of metal ions with nonsteroidal anti-inflammatory drugs (oxicams)
Nadia E. A. El-Gamel
JOURNAL OF COORDINATION CHEMISTRY (2009)
Emerging Protein Targets for Anticancer Metallodrugs: Inhibition of Thioredoxin Reductase and Cathepsin B by Antitumor Ruthenium (II)-Arene Compounds
Angela Casini et al.
JOURNAL OF MEDICINAL CHEMISTRY (2008)
Involvement of up-regulation of PUMA in non-steroidal anti-inflammatory drug-induced apoptosis
Tomoaki Ishihara et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2007)
Organometallic chemistry, biology and medicine: ruthenium arene anticancer complexes
YK Yan et al.
CHEMICAL COMMUNICATIONS (2005)
Synthesis and chemical-pharmacological characterization of the antimetastatic NAMI-A-type Ru(III) complexes (Hdmtp)[trans-RuCl4(dmso-S)(dmtp)], (Na)[trans-RuCl4(dmso-S)(dmtp)], and [mer-RuCl3(H2O)(dmso-S)(dmtp)] (dmtp=5,7-dimethyl[1,2,4]triazolo[1,5-a]pyrimidine)
AH Velders et al.
JOURNAL OF MEDICINAL CHEMISTRY (2004)
Design, synthesis, and pharmacological evaluation of pyridinic analogues of nimesulide as cyclooxygenase-2 selective inhibitors
F Julémont et al.
JOURNAL OF MEDICINAL CHEMISTRY (2004)
A phase I and pharmacological study with imidazolium-trans-DMSO-imidazole-tetrachlororuthenate, a novel ruthenium anticancer agent
JM Rademaker-Lakhai et al.
CLINICAL CANCER RESEARCH (2004)
Inhibition of cancer cell growth by ruthenium(II) arene complexes
RE Morris et al.
JOURNAL OF MEDICINAL CHEMISTRY (2001)
Share Paper
